OKYO Pharma income statement data for the quarter ended Mar 2026. This income statement covers 11 quarters of results from Mar 2021 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2021 | Mar2022 | Mar2023 | Sep2023 | Mar2024 | Sep2024 | Dec2024 | Mar2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 672.77M | ||||||||||
| Additional items | |||||||||||
| Shares Outstanding | 672.77M | 672.77M | 672.77M | 672.77M | 672.77M | 672.77M | 672.77M | 672.77M | 672.77M | 672.77M | 672.77M |